Inhibition of tumor growth by a novel engineered chimeric toxin that cleaves activated mutant and wild-type RAS

MLA

David Gius, et al. Inhibition of Tumor Growth by a Novel Engineered Chimeric Toxin That Cleaves Activated Mutant and Wild-Type RAS. Dec. 2019. EBSCOhost, https://doi.org/10.1101/2019.12.17.880187.

APA

David Gius, Vania Vidimar, Greg L. Beilhartz, Karla J. F. Satchell, Marco Biancucci, Minyoung Park, Matthew B. Kieffer, & Roman A. Melnyk. (2019). Inhibition of tumor growth by a novel engineered chimeric toxin that cleaves activated mutant and wild-type RAS. https://doi.org/10.1101/2019.12.17.880187

Chicago

David Gius, Vania Vidimar, Greg L. Beilhartz, Karla J. F. Satchell, Marco Biancucci, Minyoung Park, Matthew B. Kieffer, and Roman A. Melnyk. 2019. “Inhibition of Tumor Growth by a Novel Engineered Chimeric Toxin That Cleaves Activated Mutant and Wild-Type RAS,” December. doi:10.1101/2019.12.17.880187.